Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
| dc.contributor.author | Kilickap, S. | |
| dc.contributor.author | Ozturk, A. | |
| dc.contributor.author | Karadurmus, N. | |
| dc.contributor.author | Korkmaz, T. | |
| dc.contributor.author | Yumuk, P. | |
| dc.contributor.author | Cicin, I. | |
| dc.contributor.author | Paydas, S. | |
| dc.date.accessioned | 2024-02-23T14:49:10Z | |
| dc.date.available | 2024-02-23T14:49:10Z | |
| dc.date.issued | 2018 | |
| dc.department | NEÜ | en_US |
| dc.description.abstract | [Abstract Not Availabe] | en_US |
| dc.identifier.endpage | S478 | en_US |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.issn | 1556-1380 | |
| dc.identifier.issue | 10 | en_US |
| dc.identifier.scopusquality | Q1 | en_US |
| dc.identifier.startpage | S477 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12452/18035 | |
| dc.identifier.volume | 13 | en_US |
| dc.identifier.wos | WOS:000454014501235 | en_US |
| dc.identifier.wosquality | Q1 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.relation.ispartof | Journal Of Thoracic Oncology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Nsclc | en_US |
| dc.subject | Alk Inhibitor | en_US |
| dc.subject | Crizotinib | en_US |
| dc.title | Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey | en_US |
| dc.type | Conference Object | en_US |












